Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6

著者: Joshua A. Hill, Amalia Magaret, Ruth Hall-Sedlak, Anna V. Mikhaylova, Meei‐Li Huang, Brenda M. Sandmaier, John A. Hansen, Keith R. Jerome, Danielle M. Zerr, Michael Boeckh - Blood 2017 被引用: 83

= .001-.040). Inherited ciHHV-6 status did not significantly affect risk for chronic GVHD, hematopoietic cell engraftment, overall mortality, or nonrelapse mortality. Screening for iciHHV-6 could guide donor selection and post-HCT risk stratification and treatment. Further study is needed to replicate these findings and identify potential mechanisms.